文献速递腹部外周血管MR

速度编码相位对比MRI测量新诊断小肠克罗恩病患者肠系膜血流

Velocity-Encoded Phase-Contrast MRI for Measuring Mesenteric Blood Flow in Patients With Newly Diagnosed Small-Bowel Crohn Disease.
PubMed 文献 · AJR Am J Roentgenol · 2022-02-23

前瞻性研究纳入20例新诊断回肠克罗恩病患者和15名健康对照,采用速度编码相位对比MRI测量肠系膜血流。基线时患者肠系膜上动脉与腹主动脉血流比值(SMA-to-aorta)为0.44 vs 对照0.30(p=.003),肠系膜上静脉与腹主动脉血流比值(SMV-to-aorta)为0.36 vs 0.21(p=.002);抗TNF-α治疗6周和6个月后上述比值下降。SMA-to-aorta和SMV-to-aorta血流与CRP和粪钙卫蛋白正相关,鉴别患者与对照的AUC分别为0.79和0.82。

要点

  • 新诊断回肠克罗恩病患者的SMA-to-aorta和SMV-to-aorta血流比值高于健康对照。
  • 抗TNF-α治疗6周和6个月后,患者SMA-to-aorta和SMV-to-aorta血流比值下降。
  • SMA-to-aorta鉴别患者与对照的AUC为0.79(敏感度60%,特异度100%),SMV-to-aorta为0.82(敏感度75%,特异度87%)。

核心结论

  • 速度编码相位对比MRI可定量测量肠系膜血流,新诊断回肠克罗恩病患者与健康对照的测量值不同,且随药物治疗变化;基于MRI的肠系膜血流测量可能成为肠道炎症的新标志物。

研究设计与样本

  • 前瞻性研究纳入20例2018年12月至2021年10月新诊断的回肠克罗恩病患者(8例女性,12例男性;中位年龄14.0岁)和15名健康对照(8例女性,7例男性;中位年龄17.0岁)。

诊断标准与关键数值

  • SMA-to-aorta鉴别患者与对照的AUC为0.79(敏感度60%,特异度100%);SMV-to-aorta的AUC为0.82(敏感度75%,特异度87%)。

临床应用与阅片要点

  • 患者确诊时及启动抗TNF-α治疗6周和6个月后接受研究性MRI和实验室评估,对照接受单次研究性MRI;所有MRI均包括速度编码相位对比序列,测量腹主动脉、肠系膜上动脉和肠系膜上静脉血流。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Intestinal inflammation is associated with radiologic and histologic hyperemia. A paucity of studies have used MRI to measure mesenteric blood flow in patients with Crohn disease. OBJECTIVE. The purpose of this study was to evaluate the application of velocity-encoded phase-contrast MRI for measuring mesenteric blood flow in patients with newly diagnosed small-bowel Crohn disease. METHODS. This prospective study included 20 patients with ileal Crohn disease newly diagnosed between December 2018 and October 2021 (eight female participants, 12 male participants; median age, 14.0 years), and 15 healthy control participants (eight female participants, seven male participants; median age, 17.0 years). Patients with Crohn disease underwent investigational MRI and laboratory assessments at diagnosis and at 6 weeks and 6 months after initiating anti-tumor necrosis factor-α medical therapy; control participants underwent a single investigational MRI examination. All MRI examinations included a velocity-encoded phase-contrast acquisition, which was used to measure blood flow in the abdominal aorta, superior mesenteric artery (SMA), and superior mesenteric vein (SMV). Mann-Whitney U test was used to compare blood flow measurements (ratios of SMA and SMV blood flow to aorta blood flow [hereafter, SMA-to-aorta and SMV-to-aorta blood flow, respectively]) between groups; Friedman test was used to evaluate temporal changes in blood flow. Spearman correlation was used to assess relationships between blood flow measurements and laboratory markers of intestinal inflammation. Diagnostic performance was assessed by ROC analysis. RESULTS. At baseline, SMA-to-aorta blood flow in patients versus control participants was 0.44 versus 0.30 (p = .003), and SMV-to-aorta blood flow was 0.36 versus 0.21 (p = .002). At 6 weeks and 6 months, SMA-to-aorta blood flow in patients decreased to 0.30 and 0.27 (p < .001), and SMV-to-aorta blood flow decreased to 0.27 and 0.21 (p = .02), respectively. SMA-to-aorta and SMV-to-aorta blood flow were positively correlated with C-reactive protein (rho, 0.34 [p = .01] and 0.35 [p = .008], respectively) and fecal calprotectin (rho, 0.34 [p = .01] vs 0.47 [p < .001]). AUCs for differentiating patients from controls were 0.79 for SMA-to-aorta (sensitivity, 60%; specificity, 100%) and 0.82 for SMV-to-aorta (sensitivity, 75%; specificity, 87%) blood flow. CONCLUSION. Mesenteric blood flow is quantifiable using velocity-encoded phase-contrast MRI. The measurements differ between patients with ileal Crohn disease and healthy control participants and change in response to medical therapy. CLINICAL IMPACT. MRI-based mesenteric blood flow measurements provide a potential novel marker of intestinal inflammation.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Ata, Dillman, Gandhi, et al. Velocity-Encoded Phase-Contrast MRI for Measuring Mesenteric Blood Flow in Patients With Newly Diagnosed Small-Bowel Crohn Disease. AJR Am J Roentgenol. 2022. PMID: 35195433. doi:10.2214/AJR.22.27437

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。